- GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend beyond aiding in weight loss in people who have type 2 diabetes or obesity.
- A new review takes a look at how GLP-1 drugs may offer neuroprotective benefits.
- Since obesity can cause chronic inflammation, including inflammation in the brain, it can also increase the risk of developing neurodegenerative diseases such as Alzheimer’s disease.
- The study examines how GLP-1 medications…
Read the full article here